Kevin Smith

Kevin Smith

Auto-generated profile, based on publicly available information

Kevin Smith

KTH Royal Institute of Technology

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
4 May 2023
Verified
Book Chapter
Closed access
PDF file
BSB. Sirmacek
B. Sirmacek
SGShivam Gupta
Shivam Gupta
FMFermin Mallor
Fermin Mallor
HAH. Azizpour
H. Azizpour
Yifang BanYifang Ban
Yifang Ban
Ricardo VinuesaRicardo Vinuesa
Ricardo Vinuesa

20 March 2023 in Journal of Medical Imaging
Verified
Journal Article
Open access
PDF file
FCFernando Cossío
Fernando Cossío
HSHaiko Schurz
Haiko Schurz
MEMathias Engström
Mathias Engström
CBCarl Barck-Holst
Carl Barck-Holst
ATApostolia Tsirikoglou
Apostolia Tsirikoglou
FSFredrik Strand
Fredrik Strand
Machine learning (ML) is rapidly progressing in many scientific fields, including medicine.1 For breast cancer, we are beholding the emergence of commercially available artificial intelligence (AI) systems for breast cancer detection (AI-CADe),2 – 8 triaging, diagnosis, and risk assessment.9 If the performance of such systems proves to be accurate and robust in a clinical setting, incorporating them into the screening process can significantly benefit both the hospital and the screening participants. The most common use case, AI-CADe, would reduce radiologist workload and potentially reduce the rate of missed cancers.10 Some challenges remain despite the potential impact of adopting these technologies in the screening process. Collectively these challenges are known as the AI translational gap, which is currently under special investigation by the Federal Drug Administration in the United States of America (USA).11

1 November 2023 in British Journal of Radiology
Verified
Journal Article
Open access
MSMattie Salim
Mattie Salim
KDKarin Dembrower
Karin Dembrower
MEMartin Eklund
Martin Eklund
KSKevin Smith
Kevin Smith
FSFredrik Strand
Fredrik Strand
Objective: We aimed to evaluate the false interpretations between artificial intelligence (AI) and radiologists in screening mammography to get a better understanding of how the distribution of diagnostic mistakes might change when moving from entirely radiologist-driven to AI-integrated breast cancer screening. Methods and materials: This retrospective case–control study was based on a mammography screening cohort from 2008 to 2015. The final study population included screening examinations for 714 women diagnosed with breast cancer and 8029 randomly selected healthy controls. Oversampling of controls was applied to attain a similar cancer proportion as in the source screening cohort. We examined how false-positive (FP) and false-negative (FN) assessments by AI, the first reader (RAD 1) and the second reader (RAD 2), were associated with age, density, tumor histology and cancer invasiveness in a single- and double-reader setting. Results: For each reader, the FN assessments were distributed between low- and high-density females with 53 (42%) and 72 (58%) for AI; 59 (36%) and 104 (64%) for RAD 1 and 47 (36%) and 84 (64%) for RAD 2. The corresponding numbers for FP assessments were 1820 (47%) and 2016 (53%) for AI; 1568 (46%) and 1834 (54%) for RAD 1 and 1190 (43%) and 1610 (58%) for RAD 2. For ductal cancer, the FN assessments were 79 (77%) for AI CAD; with 120 (83%) for RAD 1 and with 96 (16%) for RAD 2. For the double-reading simulation, the FP assessments were distributed between younger and older females with 2828 (2.5%) and 1554 (1.4%) for RAD 1 + RAD 2; 3850 (3.4%) and 2940 (2.6%) for AI+RAD 1 and 3430 (3%) and 2772 (2.5%) for AI+RAD 2. Conclusion: The most pronounced decrease in FN assessments was noted for females over the age of 55 and for high density-women. In conclusion, AI could have an important complementary role when combined with radiologists to increase sensitivity for high-density and older females. Advances in knowledge: Our results highlight the potential impact of integrating AI in breast cancer screening, particularly to improve interpretation accuracy. The use of AI could enhance screening outcomes for high-density and older females.

12 June 2023 in arXiv
Verified
Preprint
Open access
PDF file
JHJohan Fredin Haslum
Johan Fredin Haslum
CMChristos Matsoukas
Christos Matsoukas
KLKarl-Johan Leuchowius
Karl-Johan Leuchowius
EMErik Müllers
Erik Müllers
KSKevin Smith
Kevin Smith
High content imaging assays can capture rich phenotypic response data for large sets of compound treatments, aiding in the characterization and discovery of novel drugs. However, extracting representative features from high content images that can capture subtle nuances in phenotypes remains challenging. The lack of high-quality labels makes it difficult to achieve satisfactory results with supervised deep learning. Self-Supervised learning methods have shown great success on natural images, and offer an attractive alternative also to microscopy images. However, we find that self-supervised learning techniques underperform on high content imaging assays. One challenge is the undesirable domain shifts present in the data known as batch effects, which are caused by biological noise or uncontrolled experimental conditions. To this end, we introduce Cross-Domain Consistency Learning (CDCL), a self-supervised approach that is able to learn in the presence of batch effects. CDCL enforces the learning of biological similarities while disregarding undesirable batch-specific signals, leading to more useful and versatile representations. These features are organised according to their morphological changes and are more useful for downstream tasks -- such as distinguishing treatments and mechanism of action.

16 July 2018 in arXiv
Verified
Preprint
Open access
PDF file
MTMattias Teye
Mattias Teye
HAHossein Azizpour
Hossein Azizpour
KSKevin Smith
Kevin Smith
We show that training a deep network using batch normalization is equivalent to approximate inference in Bayesian models. We further demonstrate that this finding allows us to make meaningful estimates of the model uncertainty using conventional architectures, without modifications to the network or the training procedure. Our approach is thoroughly validated by measuring the quality of uncertainty in a series of empirical experiments on different tasks. It outperforms baselines with strong statistical significance, and displays competitive performance with recent Bayesian approaches.

3 October 2024
Verified
Book Chapter
Closed access
PDF file
LGLennart A. Van der Goten
Lennart A. Van der Goten
KSKevin Smith
Kevin Smith
FNFor The Alzheimer’s Disease Neuroimagin
For The Alzheimer’s Disease Neuroimagin